A quiet revolution is underway in research to keep pace with changes in medical marketing
Companies in this space are expanding beyond reproductive health into areas like menopause and osteoporosis. To succeed, they'll need to re-energize their physician and patient base. Noah Pines reports
Phase III ramucirumab hit gastric cancer goals, but failed among breast cancer patients.